Detection of minimal residual disease following induction immunochemotherapy predicts progression free survival in mantle cell lymphoma: final results of CALGB 59909
      QxMD      Google Scholar   
Citation:
Haematologica vol 97 (4) 579-585
Year:
2012
Type:
Manuscript
Funding:
NCTN
Endpoint:
Secondary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
ppub
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
Parents:
None
Children:
None
Program:
OGC
Primary Committee:
Lymphoma
Sec. Committees:
   
Pharmas:
 
Grants:
 
Corr. Author:
 
Authors:
                       
Networks:
 
Study
CALGB-59909
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
2
Keywords:
minimal residual disease, progression-free survival, MCL, induction, chemotherapy